allicin has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Lv, Q; Wang, Z; Xia, Q | 1 |
| Cao, WK; Chen, XF; Gao, Y; Heng, C; Liu, YQ; Wan, YY; Xu, LJ | 1 |
2 other study(ies) available for allicin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Allicin suppresses growth and metastasis of gastric carcinoma: the key role of microRNA-383-5p-mediated inhibition of ERBB4 signaling.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disulfides; Humans; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-4; Signal Transduction; Stomach Neoplasms; Sulfinic Acids | 2020 |
[Effects of allicin on invasion and metastasis of colon cancer LoVo cell line in vitro].
Topics: Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Disulfides; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Receptors, Urokinase Plasminogen Activator; RNA, Messenger; Sulfinic Acids; Tissue Inhibitor of Metalloproteinase-2; Vascular Endothelial Growth Factor A | 2009 |